Alchemy Investments Acquisition Corp 1 (ALCY)
Alchemy Investments Acquisition Corp 1 is a special purpose acquisition company—a blank-check firm formed to identify and merge with an operating business. The company went public to raise capital for this purpose, and in 2025 it identified its target: Cartiga, LLC, a legal-claims asset management platform. As of mid-2026, the proposed merger remains pending shareholder approval, with a September 2026 deadline looming.
What is a blank-check company?
A blank-check SPAC raises money from public investors through an initial offering, then has a limited window—usually two to three years—to find and acquire a private operating company. The SPAC founders and initial investors bet that they can identify a better-than-average target. If a merger happens, the private company becomes public, and the original SPAC shareholders become shareholders in the merged entity. If no deal closes before the deadline, investors who haven’t redeemed their shares face a liquidation: the trust account is returned to those who didn’t sell during the merger vote.
Alchemy formed in 2024 and raised capital through its public offering. The merger agreement with Cartiga was signed in August 2025, committing the company to a specific path forward.
What does Cartiga do?
Cartiga is a data-driven asset management platform focused on an unconventional category: purchasing and managing legal claims and law firm partnerships. The platform uses proprietary data analytics and algorithms to assess the risk-adjusted returns on legal investments—a space that has grown as institutional capital has sought non-traditional yield sources.
The business is speculative by nature. Legal outcomes are uncertain, settlements take time, and the market for law-firm-backed securities remains small and illiquid compared to traditional equities or bonds. Cartiga’s edge, if one exists, is in its data infrastructure and its ability to spot patterns in litigation outcomes that other market participants miss.
Why pursue this merger now?
SPACs emerged as a faster, less dilutive route to going public than traditional IPOs in the early 2020s. That momentum has slowed: regulatory scrutiny, failed mergers, and poor post-merger performance have cooled investor appetite. Cartiga is pursuing a SPAC path in 2025–2026 when fewer SPACs are active, suggesting either strong conviction or limited alternatives for raising capital.
Cartiga’s target investor base—institutional allocators seeking unconventional return sources—differs from the typical SPAC shareholder base (retail traders). That mismatch creates tension: Alchemy’s shareholders will vote to approve the merger, but Cartiga’s future owners may be a different set of investors who come in via a PIPE (private investment in public equity) or who buy shares in the open market post-merger.
What are the mechanics of the deal?
As of March 2026, Alchemy was evaluating a PIPE commitment—private capital raised from institutional investors at a set price to shore up the trust account after redemptions. Merger terms would convert Cartiga into a subsidiary of the merged entity, likely rebranded as Cartiga or a holding company. Shareholders were scheduled to vote in the spring or summer of 2026, with a September 2026 deadline for deal closure.
The trust account held approximately 8.8 million dollars as of December 2025. Any redemptions by public shareholders would reduce that pool. The PIPE, if closed, would top it up. The merged company would then require working capital and growth capital—money to fund operations and expansion.
What happens if the deal doesn’t close?
If shareholders don’t approve the merger or the deal fails to close by September 2026, Alchemy will liquidate. Shareholders who didn’t redeem will receive their pro-rata share of the trust account, minus administrative costs. Shareholders who redeemed before the vote will have already exited. The $8.8 million trust balance, less costs, would be distributed. This outcome—failed closure—is not uncommon in SPAC history and typically results in shareholders losing capital or earning minimal returns.
How would an investor research this?
Start with Alchemy’s SEC filings, particularly the merger proxy statement (DEFM14A), which contains Cartiga’s financials, management bios, and risk disclosures. The trust account size, remaining capital, and PIPE commitment (if any) appear in the latest 10-K or 10-Q quarterly reports. Monitor the SEC’s EDGAR database for any updates on the merger status or shareholder redemption numbers. Watch for any 8-K filings announcing deal delays, renegotiated terms, or termination. Cartiga’s data on past litigation outcomes and investment returns—if disclosed—would shed light on whether the platform’s track record supports its valuation. Finally, note the September 2026 deadline: as that date approaches without a closed deal, liquidation risk rises sharply.